Extract
It has been reported by Wapnir et al. that fetal and neonatal rat brains are capable of converting phenylalanine to tyrosine at a rate that is about 10% that of livers from mature animals; this report led to the speculation that "the gestational role of phenylalanine hydroxylase is to supply tyrosine to the fetal brain."
As our present results show, however, the relatively high activity observed by Wapnir et' al. in rat brain extracts is caused by a nonenzymatic hydroxylation of phenylalanine under their assay conditions. The critical features of their assay are the use of relatively high (2 mM) 2-amino-6,7-dimethyl-4-hydroxytetrahydropteridine (DMPH4) concentrations and the reliance on a zero time control, i.e., a control to which trichloroacetic acid is added before incubation. Under these conditions, nonenzymatic hydroxylation of phenylalanine becomes significant. Although this nonenzymatic reaction is not troublesome when assaying tissues that have an active phenylalanine hydroxylase, such as liver, it can cause confusion when assaying a tissue with little or no hydroxylase, such as brain. Under the assay conditions used in our laboratory (0.2 rather than 2 mM DMPH4), there is essentially no difference between a zero time control and a boiled enzyme control, i.e., there is no detectable nonenzymatic hydroxylation of phenylalanine under our conditions. It can also be seen that there is no evidence for an enzyme-dependent hydroxylation under any of the assay conditions used.
With higher amounts of protein and longer times of incubation, some phenylalanine hydroxylation can be detected in a brain extract from newborn rats. The activity found is equal to 0.33 pmol phenylalanine hydroxylated/hr/g protein. This value is less than 0.05% of the value for phenylalanine hydroxylation observed with liver extracts. That this low activity is caused by tyrosine hydroxylase is indicated strongly by the essentially complete inhibition of the reaction in the presence of 3-iodotyrosine.
Speculation
There is no detectable phenylalanine hydroxylation in brain other than the very small amount caused by tyrosine hydroxylase. This finding rules out the possibility-thit brain phenylalanine hydroxylase can have a role in brain development in the normal or phenylketonuric individual.
In 197 1, Wapnir et al. (1 0 ) reported that fetal and neonatal (up to 11 days after birth) rat brains are capable of converting phepylalanine to tyrosine at a rate that is about 10% that of livers from mature animals. They concluded that the phenylalanine hydroxylase activity of brain was not caused by tyrosine hydroxylase, a brain enzyme that is known t o be capable of converting phenylalanine t o tyrosine (3) .
This report of the occurrence of phenylalanine hydroxylase in brain led t o the speculation that "the gestational role of phenylalanine hydroxylase is to supple tyrosine t o the fetal brain" (1) . If the brain phenylalanine hydroxylase played such a role, the lack of this enzyme in phenylketonuria (PKU) could be a contributing factor in the development of mental retardation in this disease.
In the present paper, we present evidence that refutes the claim of Wapnir et al. (10) for the occurrence in brain of phenylalanine hydroxylation that is not caused by tyrosine hydroxylase. The speculation regarding PKU (1) that was engendered by this report is, therefore, without a sound basis.
METHODS AND MATERIALS
Newborn and adult Sprague-Dawley rats were used in these experiments. Animals were killed by decapitation. Brains and livers were rapidly removed and homogenized in 1.5 volumes (brain) or 2 volumes ( l i v~r ) cold 0.15 M KCl. The homogenates were centrifuged at 4 for 3 0 min at 16,000 X g. The supernatant fraction was removed and kept in crushed ice until assayed within the next 2 hr. For the measurement of brain tyrosine hydroxylase, only the hindbrain was used.
IN VITRO ASSAY
Phenylalanine hydroxylase in brain and liver was assayed in two different incubation mixtures.
Wapnir's Assay Conditions (10) . Final volume was 0.5 ml; final concentrations were: potassium phosphate buffer, pH 6.8, 200 mM; L-phenylalanine (14), 4 mM (containing 1 pCi ('4~)phenylalanine) (15), DPNH, 2 mM (16); DMPH4 (17), 2 mM; supernatant proteins, 2-60 mg/ml. The tubes, open, were incubated for 20-40 min at 37 and the reaction stopped with 1.0 ml 12% trichloroacetic acid (TCA). The precipitated proteins were removed by centrifugation and radioactivity in tyrosine and phenylalanine determined on an aliquot of the supernatant solution after separation by thin layer chromatography on cellulose plates (18) , using the following solvent: chloroform, methanol, water, ammonia (2911 611 14, V/V).
Kaufman's Assay Conditions. Final volume was 0.05 ml; final concentrations were potassium phosphate buffer, pH 6.8, 100 mM; L-phenylalanine (14), 2 mM (containing 0.1 pCi (' C)phenylalanine) (1 5); glucose, 7 mM; glucose dehydrogenase, 228 U/ml (containing catalase in excess); sheep liver dihydropteridine reductase, 200 pg/ml; TPNH (16), 0.2 mM; DMPH4, 0.2 mM (17), or tetrahydrobiopterin (19), 0.03 mM; supernatant proteins, 5.0-7.0 omg/ml. The tubes, open, were incubated for 20-60 min at 37 and the reaction stopped with 0.01 ml of 20% trichloroacetic acid. Tyrosine formation was measured as described above.
In Vitro Assay for Phenylalanine Hydroxylation by Brain Tyrosine Hydroxylase. Final volume was 0.05 ml; final concentrations were: potassium phosphate buffer, pH 6.2, 100 mM; glucose dehydrogenase, 228 U/ml; sheep liver dihydropteridine reductase, 200 ,ug/ml; glucose, 7 mM; TPNH (16) , 0.2 mM; L-phenylalanine (14), 0.05 mM (containing 0.1 pCi (' C)phenylalanine) (1 5); semicarbazide, 2.5 X 10 -4 M; N-methyl-N-3-hydroxyphenylhydrazine (NSD-1034) (20), 1 X M; tetrahydrobiopterin (19) , 0.3 mM; supernatant proteins, 8.4 mg/ml. The tubes, open, were incubated for 60 min at 37' and the reaction stopped with 0.01 ml of 20% trichloroacetic acid. Dihydroxyphenylalanine, tyrosine, and phenylalanine were separated by thin layer chromatography on cellulose plates (18) using the solvent described above.
In all assays in which a boiled extract was used as a control, the following procedure was used. The volume of fresh supernatant needed for the experiment was placed in a tube and heated in boiling water for 5 min. After cooling t o room temperature the other components of the incubation mixture were added and the reaction started by addition of the tetrahy dropterin. Table 1 shows results of experiments which duplicate those reported by Wapnir et al. (10) with newborn rats (day 0 ) . The critical features of their assay are the use of relatively high DMPH4 concentrations and the reliance on a zero time control, i.e., a control to which TCA is added before any incubation. A comparison of experiments 1 and 6 shows that there is more phenylalanine hydroxylation in the experiment with incubation ( experzment 6) than in the zero time experiment (experiment I ) . The difference in the two experiments is equal to 63 pmol phenylalanine hydroxylated/ hr/g protein. This extent of hydroxylation is close t o the value of 53 rf-13 pmollhrjg protein reported by Wapnir et al. (10) . Furthermore, the hydroxylation is dependent on DMPH4 (compare experiments 4 and 6 ) and shows some dependence (but not a linear one) on the time of incubation. It should be noted, however, that the hydroxylation reaction shows no proportionality with the amount of protein used, in the range of 2-6 mg protein/ml. This last finding indicates that either the assay is not a valid one for the quantitative determination of hydroxylase activity or that the hydroxylation measured under these conditions is a nonenzymatic one.
RESULTS
That the latter explanation is the correct one is shown by the dramatic difference between the boiled enzyme control and the zero time control. A comparison of experiment 1 and experiments 2 and 3 shows that there is time-dependent hydroxylation of phenylalanine in the boiled enzyme control over and above that in the zero time control. Furthermore, there is n o more hydroxylation in the mixtures which contain native enzyme than in those which contain boiled enzyme (compare experiments 2 and 6 and experiments 3 and 7 ) . In other words, under these conditions, there is no detectable enzyme-dependent hydroxylation of phenylalanine by these . brain preparations.
The results shown in Table 2 demonstrate that the nonenzymatic hydroxylation observed by Wapnir et al. ( l o ) , which these authors confused with an enzyme-catalyzed one, is caused by the use of high DMPH4 concentrations in their assay. Under the assay conditions used in this laboratory (0.2 rather than 2mM DMPH4), there is essentially n o difference =Average value for three different experiments. In each experiment the brains of two to six newborn rats were pooled. 
-amino-6,7-dimethyl-4-hydroxytetrahydropteridine (DMPH,).
Kaufman's assay conditions with 0.3 mM tetrahydrobiopterin. 'Kaufman's assay conditions with 0.2 mM DMPH,. All tubes contained 6.8 mg/ml of brain supernatant proteins. between a zero time control and a boiled enzyme control, i.e., there is n o detectable nonenzymatic hydroxylation of phenylalanine under our conditions. It can also be seen, in confirmation of the results shown in Table 1 , that there is no evidence for an enzyme-dependent hydroxylation under any of the assay conditions used. Table 3 presents results of phenylalanine hydroxylase activity determinations in livers of adult female rats under both assay conditions. It can be seen that the type of control used makes only a trivial difference when a tissue with high phenylalanine hydroxylase activity, such as liver, is used, and that comparable values are obtained under both assay conditions. The rate of hydroxylation with liver extracts is equal t o about 4 0 0 pmol/hr/g protein.
Finally, the results in Table 4 show that by the use of higher amounts of protein and longer times of incubation, some phenylalanine hydroxylation can be detected in a brain extract from newborn (1 1 days) rats. The activity found is equal t o 0.33 ymol phenylalanine hydroxylated/hr/g protein. This value is less than 0.5% the value for phenylalanine hydroxylation in brain reported by Wapnir et al. (10) and about 0.05% of the value for phenylalanine hydroxylation observed with liver extracts. That this low activity is caused by tyrosine hydroxylase is strongly indicated by the essentially complete inhibition of the reaction (down t o the levels of the boiled enzyme and zero time controls) in the presence of the tyrosine hydroxylase inhibitor, 3-iodotyrosine.
DISCUSSION
There have been numerous surveys of the tissue distribution of phenylalanine hydroxylase and they have failed consistently t o detect this enzyme in brain (6, 8, 12) . The recent report (10) that the specific activity of phenylalanine hydroxylase in rat brain extracts is about 10% as great as that of liver extracts from adult rats was therefore provocative.
As our present results show, however, the relatively high activity observed b y Wapnir et al. (10) in rat brain extracts is caused by a nonenzymatic hydroxylation of phenylalanine under their assay conditions. Under these conditions, there is n o more hydroxylation in a reaction mixture containing native enzyme than there is in a mixture containing heat-inactivated enzyme.
It may be instructive t o analyze the difficulties inherent in the hydroxylase assay employed by Wapnir et al. (10) . The main problem is the use of concentrations of DMPH4 (2 mM) which are 10 times higher than those used routinely. Under these conditions, nonenzymatic hydroxylation of phenylalanine becomes significant (see Tables 1 and 2 ). Although this nonenzymatic reaction is not troublesome when assaying tissues that have an active phenylalanine hydroxylase, such as liver (see Table 3 ), it can cause confusion when assaying a tissue with little o r n o hydroxylase, such as brain (13) .
A treacherous characteristic of the nonenzymatic reaction is that it has a pH optimum of around 6.9-7.0 (9). This property of the nonenzymatic hydroxylating system probably accounts for the observation that there is less conversion of phenylalanine t o tyrosine in a zero time control ( t o which TCA is added before incubation) than there is in a boiled enzyme control. Wapnir et al. (10) reported that the ability of brain extracts 'Average value for two different experiments. All assay tubes contained 5 mg/ml of liver supernatant proteins. Incubation times were 20 min. t o catalyze the conversion of phenylalanine t o tyrosine was lost when the extracts were heated t o 45' (a half-life of 11 min). Although this finding would appear to support the idea that these authors were measuring an enzyme-catalyzed hydroxylation reaction, we have shown that the phenylalanine hydroxylating ability of brain extracts is stable t o boiling (see Table 1 ). Because crude tissue extracts, such as those used in the previous (10) and the present study, probably contain enzymes that can both degrade (e.g., pterin deaminase, xanthine oxidase) and regenerate (e.g., dihydropteridine reductase) tetrahydropterins, the hydroxylation reaction could be labile t o heating t o 45' (10) because of the selective inactivation of enzymes that regenerate the tetrahydropterin, thereby increasing the rate of pterin destruction. Inasmuch as nonenzymatic hydroxylation of phenylalanine is dependent on high tetrahydropterin concentrations, any procedure that leads t o a lower concentration of the tetrahydropterin could reduce the rate of hydroxylation.
Because they were studying the nonenzymatic hydroxylation of phenylalanine, it is not surprising that Wapnir et al. (10) found that this hydroxylation reaction was not inhibited by a tyrosine hydroxylase inhibitor. As we have shown (see Table 4 ), the very low enzymatic hydroxylation of phenylalanine by brain extracts is essentially completely inhibited by a tyrosine hydroxylase inhibitor, 3-iodotyrosine.
As mentioned earlier, Bessman ( I ) , referring t o the report of Wapnir e t al. (10) on the occurrence in brain of phenylalanine hydroxylase as well as t o his own apparent confirmation of this finding, has speculated about the role in normal brain development of brain phenylalanine hydroxylase. Specifically, he has proposed that "the gestational role of phenylalanine hydroxylase is t o supply tyrosine t o t h e fetal brain" (1). Because we have shown that there is n o enzymatic phenylalanine hydroxylation in brain (other than the very small amount caused by tyrosine hydroxylase), it is clear that brain phenylalanine hydroxylase can have n o role, gestational or otherwise, in brain development in the normal or the phenylketonuric individual.
Parenthetically, it should be noted that there is no evidence in favor of the idea that there is a primary defect in brain tyrosine hydroxylase in PKU. Although it is possible that the activity of brain tyrosine hydroxylase is adversely affected in PKU by the accumulation of phenylalanine and/or its metabolites, this effect would be secondary t o the primary defect in phenylalanine hydroxylase.
SUMMARY
There is n o detectable phenylalanine hydroxylase activity in brain of newborn and adult rats other than that of tyrosine hydroxylase. Evidence is presented that the significant activity reported previously by Wapnir e t al. (10) is due t o a nonenzymatic conversion of phenylalanine t o tyrosine under the particular assay conditions that were used.
